Knotnerus Tim Jasper
Chief Executive Officer
Knotnerus Tim Jasper has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Oct 7, 2026.
On the most recent filing, Knotnerus Tim Jasper is listed as Chief Executive Officer at AgomAb Therapeutics NV. Inside the rolling window, Knotnerus Tim Jasper reported 2 open-market purchases totaling $94K in AGMB and no open-market sales. The largest disclosed transaction in the window is a purchase of 6,000 AGMB shares on Oct 5, 2026, worth $51K.
Companies traded
Other insiders at AGMB
Insider Buying
$94K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Knotnerus Tim Jasper made?
Knotnerus Tim Jasper has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Knotnerus Tim Jasper trade?
Knotnerus Tim Jasper has filed SEC Form 4 disclosures for 1 company, including AGMB.
When was Knotnerus Tim Jasper's most recent SEC Form 4 filing?
Knotnerus Tim Jasper's most recent SEC Form 4 filing on Tracefour is dated Oct 7, 2026.
What is Knotnerus Tim Jasper's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Knotnerus Tim Jasper is listed as Chief Executive Officer.
What is Knotnerus Tim Jasper's total buy and sell value in the current window?
Inside the rolling retention window, Knotnerus Tim Jasper bought $94K and sold $0 based on SEC Form 4 filings.
What was Knotnerus Tim Jasper's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 6,000 AGMB shares on 2026-10-05, worth $51K, per SEC Form 4 filings.